ZIVOZivo Bioscience, Inc.

About Zivo Bioscience, Inc. (ZIVO)

Zivo Bioscience, Inc. (ZIVO) is a Biotechnology company headquartered in Bloomfield Hills, MI, United States whose shares trade over-the-counter on the OTCQB tier.

Zivo Bioscience, Inc. is a Michigan-based biotech company engaged: 1) in the development and commercialization of therapeutic products containing bioactive compounds extracted or derived from its proprietary algal cultures for use as pharmaceuticals for treatment of disease in animals and humans; and 2) the development, manufacturing, marketing, and selling of nutritional products from or including our proprietary algal cultures for use as a food or a food additive to promote the general health of humans and animals.

Products and services

100% pure algal biomass dried and packaged as a food for human consumption. A product candidate for the treatment of coccidiosis in broiler chickens.

ZIVO key facts

Ticker symbol

ZIVO

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

Bloomfield Hills, MI, United States

Country of incorporation

US

Year of incorporation

2003

Employees

8

Estimated market cap

$64.45M (as of Apr 10, 2025)

Shares outstanding

3,791,093

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Zivo Bioscience, Inc. leadership

• John Bernard Payne — CEO
• Keith R Marchiando — CFO, Company Secretary

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with Z